Based on analysts offering 12 month price targets for TBSA in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .

The patient in this study is a 7-year-old child carrying a homozygous mutation in the LAMB3 gene, which had led to complete epidermal loss on about 60% of his total body surface area (TBSA). The ...